KEAP1 and lung carcinoid tumor: Anyhow, the general observation of a deregulation of KEAP1/NRF2 axis in lung carcinoid provided the opportunity to consider new therapeutic approaches that directly involve epi-drugs or drugs affecting redox processes to support the chemo and radio-therapeutic options strictly related to the generation of ROS [62].